
Predictive Oncology POAI
Geschäftsbericht 2025
hinzugefügt 31.03.2026
Predictive Oncology DSO 2011-2026 | POAI
DSO Jährlich Predictive Oncology
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96.5 | 671 | 68.3 | 83.1 | 78.5 | 74.9 | 76.8 | 189 | 449 | 31.1 | 21.4 | 22.1 | 77.7 | 76.8 | 182 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 671 | 21.4 | 147 |
DSO Vierteljährlich Predictive Oncology
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 617 | 1.41 K | 38.9 | - | 9.94 K | 608 | 7.39 K | - | 65.8 | 66.4 | 117 | - | 66.2 | 73.8 | 89.8 | - | 68.6 | 60.1 | 84.9 | - | 48.8 | 128 | 85.7 | - | -61.7 | -61.7 | -55 | - | -32.9 | -22.1 | 41 | - | 82.3 | 117 | 46 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 9.94 K | -61.7 | 778 |
DSO anderer Aktien in der Medizinische Instrumente
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
The Cooper Companies
COO
|
68.9 | $ 59.8 | -0.96 % | $ 11.9 B | ||
|
Atrion Corporation
ATRI
|
0.0506 | - | - | $ 810 M | ||
|
Luminex Corporation
LMNX
|
58.6 | - | - | $ 1.75 B | ||
|
iRhythm Technologies
IRTC
|
38 | $ 115.3 | 1.0 % | $ 3.69 B | ||
|
ICU Medical
ICUI
|
29.7 | $ 119.07 | -3.19 % | $ 2.93 B | ||
|
Akers Biosciences, Inc.
AKER
|
9.92 | - | -9.52 % | $ 20.6 M | ||
|
Intuitive Surgical
ISRG
|
49.9 | $ 422.83 | -1.22 % | $ 151 B | ||
|
Repro Med Systems
KRMD
|
52.9 | $ 3.96 | -0.63 % | $ 183 M | ||
|
Alcon
ALC
|
71 | $ 63.71 | -0.48 % | $ 40.4 B | ||
|
LeMaitre Vascular
LMAT
|
42.9 | $ 97.24 | -2.27 % | $ 2.2 B | ||
|
Masimo Corporation
MASI
|
12.7 | $ 178.36 | - | $ 9.51 B | ||
|
Antares Pharma, Inc.
ATRS
|
123 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
65.5 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
91.1 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
75.4 | - | -0.05 % | $ 10.3 B | ||
|
Ekso Bionics Holdings
EKSO
|
207 | - | - | $ 28.6 M | ||
|
Envista Holdings Corporation
NVST
|
53.2 | $ 23.53 | -1.34 % | $ 3.95 B | ||
|
Varian Medical Systems, Inc.
VAR
|
123 | - | -0.02 % | $ 16.3 B | ||
|
electroCore
ECOR
|
13.6 | $ 6.0 | -6.69 % | $ 50.9 K | ||
|
Haemonetics Corporation
HAE
|
54.9 | $ 57.22 | 0.18 % | $ 2.88 B | ||
|
Isoray
ISR
|
353 | - | 0.03 % | $ 108 M | ||
|
Glaukos Corporation
GKOS
|
44 | $ 142.59 | 0.31 % | $ 6.91 B | ||
|
STAAR Surgical Company
STAA
|
38.2 | $ 32.51 | 1.56 % | $ 1.61 B | ||
|
STERIS plc
STE
|
68.6 | $ 212.38 | -1.67 % | $ 20.9 B | ||
|
Teleflex Incorporated
TFX
|
184 | $ 129.68 | -0.46 % | $ 5.79 B | ||
|
InfuSystem Holdings
INFU
|
56.1 | $ 8.68 | 0.52 % | $ 179 M | ||
|
Microbot Medical
MBOT
|
167 | $ 1.89 | 1.89 % | $ 86.5 M | ||
|
Milestone Scientific
MLSS
|
9.67 | $ 0.33 | -3.06 % | $ 27.1 M | ||
|
Merit Medical Systems
MMSI
|
47.4 | $ 61.52 | -1.66 % | $ 3.64 B | ||
|
Utah Medical Products
UTMD
|
154 | $ 63.27 | -0.68 % | $ 205 M | ||
|
West Pharmaceutical Services
WST
|
66.9 | $ 304.2 | 1.33 % | $ 22 B | ||
|
Pulse Biosciences
PLSE
|
143 | $ 24.37 | -10.07 % | $ 1.64 B | ||
|
DENTSPLY SIRONA
XRAY
|
64.3 | $ 9.96 | -4.37 % | $ 1.99 B | ||
|
Retractable Technologies
RVP
|
74.8 | $ 0.67 | -3.48 % | $ 20.1 M | ||
|
Pro-Dex
PDEX
|
83.1 | $ 60.46 | 3.09 % | $ 199 M | ||
|
BioLife Solutions
BLFS
|
31.2 | $ 20.35 | -3.37 % | $ 972 M | ||
|
Stereotaxis
STXS
|
54.5 | $ 1.89 | -3.08 % | $ 172 M | ||
|
Baxter International
BAX
|
52.6 | $ 17.29 | -2.76 % | $ 8.87 B | ||
|
ResMed
RMD
|
60.7 | $ 202.34 | -0.06 % | $ 29.6 B | ||
|
AtriCure
ATRC
|
43.4 | $ 27.89 | -0.92 % | $ 1.33 B | ||
|
Harvard Bioscience
HBIO
|
65.2 | $ 5.27 | -4.53 % | $ 234 M | ||
|
NeuroMetrix
NURO
|
42.8 | - | 5.05 % | $ 9.02 M | ||
|
AngioDynamics
ANGO
|
54 | $ 10.87 | -1.45 % | $ 444 M | ||
|
Becton, Dickinson and Company
BDX
|
50.4 | $ 142.87 | -1.11 % | $ 41.1 B | ||
|
Nephros
NEPH
|
40.7 | $ 3.18 | -4.79 % | $ 33.7 M | ||
|
OraSure Technologies
OSUR
|
73 | $ 3.07 | 3.9 % | $ 226 M | ||
|
Repligen Corporation
RGEN
|
72.4 | $ 104.92 | 1.49 % | $ 5.9 M |